Hepatitis C virus infection associated with an increased risk of deep vein thrombosis: A population-based cohort study

Medicine (United States)

Volumn 94, Issue 38, 2015, Pages

  Wang, Chun Cheng ^a,b   Chang, Chiz Tzung ^c,d   Lin, Cheng Li ^c,d   Lin, I Ching ^e,f   Kao, Chia Hung ^c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Buddhist Tzu Chi Medical Foundation   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX; VIRUS HEPATITIS; CHRONIC HEPATITIS C; COMPLICATION; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; TAIWAN; VENOUS THROMBOSIS;

AGED; COHORT STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; TAIWAN; VENOUS THROMBOSIS;

EID: 84942523039     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001585     Document Type: Article

References (42)

1. Flamm SI. Chronic hepatitis C virus infection. JAMA. 2003;289:413-417.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
3. Nguyen LH, Nguyen MH. Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther. 2013;37:921-936.
4. Liao CC, Su TC, Sung FC, et al. Does hepatitis C virus infection increase risk of stroke? A population-based cohort study. PLos One. 2012;7:e31527.
5. Bedimo R, Westfall AO, Mugavero M, et al. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIVinfected patients. HIV Med. 2010;11:462-468.
6. Eleftheriadis N, Makris P. Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden. Ther Clin Risk Manag. 2010;6:539-541.
7. Mantarro S, Tuccori M, Pasqualetti G, et al. Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient. BMC Geriatr. 2012;12:69.
8. Kida Y, Maeshima E, Yamada Y. Portal vein thrombosis in a patients with hepatitis C virus-related cirrhosis complicated with antiphospholipid syndrome. Rhuematol Int. 2009;29:1495-1498.
9. Heit JA. Venous thromboembolism: disease burden, outcomes, and risk factors. J Thromb Haemost. 2005;3:1611-1617.
10. Ng KJ, Lee YK, Huang MY, et al. Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan. J Thromb Haemost. 2015;13:206-213.
11. Lesmana CRA, Inggriani S, Cahyadinata L, et al. Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int. 2010;4:433-438.
12. Northup PG, McMahon MM, Ruhl AP, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006;101:1524-1528.
13. Gulley D, Teal E, Suvannasankha A, et al. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci. 2008;53:3012-3017.
14. Søgaard KK, Horváth-Puhó E, Grønbæk H, et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol. 2009;104:96-101.
15. Peck-Radosavljevic M. Review article: coagulation disorders in chronic liver disease. Aliment Pharmacol Ther. 2007;26(Suppl 1):21-28.
16. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of chronic hepatitis C as the cause of the antiphospholipid syndrome. Hepatology. 1996;23:199-204.
17. Violi F, Ferro D, Basili S, et al. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. J Invest Med. 1995;43:550-554.
18. Pawlotsky JM, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective casecontrol study. Hepatology. 1994;19:841-848.
19. Tripodi M, Branchi A, Chantarangkul V, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis. 2011;31:165-172.
20. Carmassi F, Morale M, Puccetti R, et al. Coaglation and fibrinolytic system impairment in insulin depedent diabetes mellitus. Thromb Res. 1992;67:643-654.
21. Pomero F, Di Minno MND, Fenoglio L, et al. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetol. 2015 April 9. [Epub ahead of print].
22. Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Ann Intern Med. 2002;162:1182-1189.
23. Petrauskiene V, Falk M, Waernbaum I, et al. The risk of venous thromboembolism is markedly elevated in patients with diabetes mellitus. Diabetologia. 2005;48:1017-1121.
24. Heit JA, Leibson CL, Ashrani AA, et al. Is diabetes mellitus an independent risk factor for venous thromboembolism? A populationbased case-control study. Arterioscler Thromb Vasc Biol. 2009;29:1399-1405.
25. Wattanakit K, Lutsey PL, Bell EJ, et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost. 2012;108:508-515.
26. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162:975-982.
27. Bai J, Ding X, Du XH, et al. Diabetes is associated with increased risk of venous thromboembolism: A systematic review and metaanalysis. Thromb Res. 2014 (in press).
28. Piazza G, Goldhaber SZ, Kroll A, et al. Venous thromboembolism in patients with diabetes mellitus. Am J Med. 2012;125:709-716.
29. Lerstad G, Brodin EE, Enga KF, et al. Hyperglycemia, assessed according to HBA1c, and future risk of venous thromboembolism: the Tromsø study. J Thromb Haemost. 2014;12:313-319.
30. Bell EJ, Selvin E, Lutsey PL, et al. Glycemia (hemoglobin A1c) and incidence venous thromboembolism in the Atherosclerosis Risk in Communities cohort study. Vasc Med. 2013;18:245-250.
31. Northup PG, Sundaram V, Fallon MB, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2007;6:2-9.
32. Gaborit FS, Overvad K, Nørgaard M, et al. Alcohol intake and risk of venous thromboembolism. A Danish follow-up study. Thromb Haemost. 2013;110:39-45.
33. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005;3:292-299.
34. Blasco C, Caballería J, Deulofeu R, et al. Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. Alcohol Clin Exp Res. 2005;29:1044-1048.
35. Zöller B, Ji J, Sundquist J, et al. Alcohol use disorders are associated with venous thromboembolism. J Thromb Thrombolysis. 2015;40:167-173.
36. Hansen-Krone IJ, Brækkan SK, Enga KF, et al. Alcohol consumption, types of alcohol beverages and risk of venous thromboembolism - The Tromsø Study. Thromb Haemost. 2011;106:272-278.
37. Calvaruso V, Maimone S, Gatt A, et al. Coagulation and fibrosis in chronic liver disease. Gut. 2008;57:1722-1727.
38. Hodowanec AC, Lee RD, Brady KE, et al. A matched crosssectional study of the association between circulating tissue factor activity, immune activation, and advanced liver fibrosis in hepatitis C infection. BMC Infect Dis. 2015;15:190.
39. Honda K, Ando A, Endo M, et al. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukaemia. Am J Kidney Dis. 1997;30:123-130.
40. Ravandi-Kashani F, Cortes J, Kantarjian HM. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogeous leukemia. Coincidence or true side effect? Cancer. 1999;85:2583-2588.
41. Okuse C, Adachi K, Katakura Y, et al. A case of deep vein thrombosis associated with pegylated interferon a2b plus ribavirin treatment of chronic hepatitis C. J Gastroenterol. 2006;41:1231-1236.
42. Cheng CL, Yang Kao YH, Lin SJ, et al. Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20:236-242.